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The cardiac voltage gated Ca2+ current (ICa) is critical to the electrophysiological properties,
excitation-contraction coupling, mitochondrial energetics, and transcriptional regulation in
heart. Thus, it is not surprising that cardiac ICa is regulated by numerous pathways. This
review will focus on changes in ICa that occur during the cardiac action potential (AP),
with particular attention to Ca2+-dependent inactivation (CDI), Ca2+-dependent facilitation
(CDF) and how calmodulin (CaM) and Ca2+-CaM dependent protein kinase (CaMKII)
participate in the regulation of Ca2+ current during the cardiac AP. CDI depends on CaM
pre-bound to the C-terminal of the L-type Ca2+ channel, such that Ca2+ influx and Ca2+
released from the sarcoplasmic reticulum bind to that CaM and cause CDI. In cardiac
myocytes CDI normally pre-dominates over voltage-dependent inactivation. The decrease
in ICa via CDI provides direct negative feedback on the overall Ca2+ influx during a single
beat, when myocyte Ca2+ loading is high. CDF builds up over several beats, depends on
CaMKII-dependent Ca2+ channel phosphorylation, and results in a staircase of increasing
ICa peak, with progressively slower inactivation. CDF and CDI co-exist and in combination
may fine-tune the ICa waveform during the cardiac AP. CDF may partially compensate
for the tendency for Ca2+ channel availability to decrease at higher heart rates because
of accumulating inactivation. CDF may also allow some reactivation of ICa during long
duration cardiac APs, and contribute to early afterdepolarizations, a form of triggered
arrhythmias.
Keywords: CaMKII, calcium channel, calcium current inactivation, calcium current facilitation, calcium current
staircase
INTRODUCTION
The cardiac L-type Ca2+ channel (LTCC) current (ICa) is an
important contributor to overall cardiac electrophysiology and
arrhythmias, excitation-contraction coupling (ECC; it causes fur-
ther intracellular Ca2+ release and activation of the myofila-
ments), mitochondrial energy regulation, cell death and tran-
scriptional regulation (Bers, 2008). ICa is mainly via the Cav1.2 α1
LTCC isoform, although the Cav1.3 isoform is expressed in some
atrial cells (especially pacemaker cells). That pore-forming α1
subunit also carries the intrinsic voltage-dependent gating prop-
erties (Perez-Reyes et al., 1989) and many key regulatory sites.
However, the mature LTCC in heart is a complex containing also
a β as well as an α2-δ subunit that influence LTCC trafficking and
gating (Shirokov et al., 1998; Bichet et al., 2000; Wei et al., 2000;
Dzhura and Neely, 2003). Cav1.2 has four major domains (I-
IV), each of which contains six transmembrane segments (S1-S6),
where positive charges in the S4 segments participate as voltage
sensors and the S5-S6 loop is the locus of the ion-conducting pore
(Bers, 2001).
The rapid upstroke or phase 0 of the cardiac action potential
(AP) is driven by Na+ current (INa) in most cardiac myocytes,
and causes voltage-dependent activation of ICa. In pacemaker
cells in the sino-atrial and atrio-ventricular node, it is ICa acti-
vation that is responsible for the rapid upstroke of the AP. ICa
activation is a bit slower than INa activation, but starts early dur-
ing the cardiac AP. The early repolarization phase of the AP (phase
1) can enhance ICa because of an increase in electrochemical
driving force, i.e., membrane potential (Em) is further from the
Ca2+ equilibrium potential (ECa; Sah et al., 2002). However, both
depolarization and the rise in local intracellular [Ca2+] ([Ca2+]i)
begin the processes of voltage- and Ca2+-dependent inactivation
(VDI and CDI), which continues during the plateau phase of
the AP (phase 2) causing a progressive decrease in ICa. As rapid
and terminal AP repolarization ensue (phase 3) the LTCC under-
goes de-activation, but then recovery from inactivation is both
time and Em-dependent. Thus, for LTCC to recover full availabil-
ity between beats, some time must elapse and that recovery time
depends on Em (e.g., at −80 and −50mV the time constant is
about 100 and 400ms, respectively).
ICa amplitude and gating properties are influenced by myr-
iad regulatory pathways, but here we will focus on the Ca2+-
dependent mechanisms that shape the ICa occurring during the
AP in ventricular myocytes. Hence, this review will describe
how the Ca2+ sensing protein calmodulin (CaM) mediates CDI,
and is involved in the activation of CaMKII, a serine/threonine-
specific protein kinase which is a key mediator of ECC. Note
that, although CaMKII activation can also be Ca2+-independent
(see accompanying article by Erickson, 2014), here we will focus
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on the main activation mechanism, which is Ca2+/CaM depen-
dent. Moreover, the particular structure of this kinase (well
described in this series by Pellicena and Schulman, 2014) con-
fers to CaMKII the ability to integrate oscillatory Ca2+ signals,
because CaMKII activity depends on both frequency and dura-
tion of previous Ca2+/CaM pulses (De Koninck and Schulman,
1998; Saucerman and Bers, 2008).We will show how the CaMKII-
dependent LTCC phosphorylation mediates the Ca2+-dependent
facilitation (CDF) of ICa, and how this process can eventually lead
to Em or Ca2+ instabilities in ventricular myocytes.
Ca2+- vs. Em-DEPENDENT INACTIVATION OF ICa
Inactivation of ICa is driven by VDI and CDI (Kass and
Sanguinetti, 1984; Lee et al., 1985; Hadley and Hume, 1987).
Several studies have shown that the Ca2+-sensing protein CaM
mediates CDI by interacting with the carboxyl tail of the LTCC
α1 subunit (Zuhlke and Reuter, 1998; Peterson et al., 1999; Qin
et al., 1999; Zuhlke et al., 1999; Pate et al., 2000), a cytoplasmic
region that contains an EF-hand region and an IQ motif. At rest,
CaM is pre-bound to the LTCC at or near the IQ motif (Erickson
et al., 2001; Pitt et al., 2001). Upon ICa activation and conse-
quent Ca2+ release from the sarcoplasmic reticulum (SR), local
[Ca2+]i rises, causing Ca2+ to bind to CaM and induce inacti-
vation. The details of the CDI process are not totally resolved,
and may involve multiple regions of the channel, including the
I-II loop that is thought to be key for VDI (Kim et al., 2004;
Cens et al., 2006). An intriguing new hypothesis has emerged
from detailed studies from the Yue lab (Ben Johny et al., 2013).
During diastole, the C-lobe of apoCaM (CaM without any Ca2+
bound) would be associated with the IQ domain, and its N-lobe
associated with the pre-IQ domain (between the IQ locus and
the upstream EF-hand domain). Ca2+ binding to the N-lobe of
CaM (the faster, low-affinity site) would cause the N-lobe to shift
and bind to part of the LTCC N-terminal domain (which they
call the NSCaTE module), and thereby trigger N-lobe CDI. Then
when Ca2+ also binds to the C-lobe of CaM (the higher affin-
ity, slower binding lobe) the C-lobe shifts its binding from the IQ
domain to a position just upstream of the Pre-IQ region where
the N-lobe had been bound. If Ca2+ binds only to the C-lobe
(e.g., if the N-lobe is unavailable) then the C-lobe does a simi-
lar sort of shift on its own, and mediates C-lobe CDI. For cardiac
Cav1.2 channels, overall CDI and C-lobe-CDI are relatively sim-
ilar, while N-lobe CDI alone was not apparent (Peterson et al.,
1999). That differs from some neuronal P/Q, N or R type Ca2+
channels, where N-lobe CDI seems to be dominant (Liang et al.,
2003).
Figure 1A shows ICa inactivation kinetics in a rabbit ventric-
ular myocyte under different Ca2+ conditions. The time to half
inactivation (t1/2) increases from 17 to 37ms when normal Ca2+
transients are abolished (e.g., by buffering the intracellular Ca2+
with 10mM EGTA). Note that EGTA is a relatively slow buffer
and cannot abolish very local [Ca2+] elevation around the mouth
of the channel (although in this case SR Ca2+ release is pre-
vented). In absence of extracellular Ca2+, LTCC are permeable
to Ba2+, and this current (IBa) has been often studied to dif-
ferentiate VDI and CDI (Lee et al., 1985; Peterson et al., 2000;
Cens et al., 2006), despite a modest ability of Ba2+ to induce
inactivation (Ferreira et al., 1997). When Ba2+ is the charge car-
rier (and intracellular Ca2+ is buffered), IBa inactivation is further
slowed (t1/2 = 161ms).
In the absence of divalent ionic species, LTCC is perme-
able to monovalent cations and is referred to as non-specific
monovalent current (INS, mostly carried by Na+ and Cs+). INS
inactivates only very slowly at this voltage at room temperature
(t1/2 > 500ms; Figure 1A), but exhibits VDI, which becomes
faster at more positive voltages (Hadley and Hume, 1987; Grandi
et al., 2010). INS inactivation is incomplete (after 500ms) even
at more positive Em (Figure 1B). The additional ICa inactivation
at intermediate Em has an U-shaped Em-dependence (as does
inward ICa amplitude, maximal at about 0mV), reflecting the
contribution of CDI. Note that at +50–60mV little Ca2+ enters
during ICa, and the extent of ICa and INS inactivation is sim-
ilar. It is tempting to speculate that INS inactivation properties
might provide pure VDI characteristics that are relevant for ICa.
However, INS can actually inactivate faster than IBa at positive
voltages, so we think that using INS to assess VDI characteris-
tics for ICa is likely to be invalid (Grandi et al., 2010). However,
IBa inactivation is also not purely VDI, because inactivation is
IBa-amplitude dependent (Brunet et al., 2009) and Ba2+ can par-
tially substitute for Ca2+ in CDI (Ferreira et al., 1997). To resolve
this we have attempted to carefully account for the weak Ba2+-
dependent inactivation and refine the characteristics of VDI vs.
CDI in cardiac myocytes in a computational analysis (Morotti
et al., 2012). That is, most prior work using IBa to characterize
VDI had slightly overestimated VDI. This is certainly not meant
to discourage the use of IBa vs. ICa as a means to study CDI,
just that this IBa is not entirely devoid of divalent-dependent
inactivation.
Given the role of ICa in sustaining the AP plateau, CDI and
VDI are important determinant for AP duration (APD) regula-
tion. Inhibition of ICa inactivation induces AP prolongation, and
has pro-arrhythmic consequences (see section “Arrhythmogenic
consequences of CaMKII-dependent ICa effects”). For example,
impaired VDI has been observed in Timothy syndrome (Splawski
et al., 2004, 2005; Brunet et al., 2009), an inherited disease char-
acterized by severe ventricular arrhythmias and sudden cardiac
death. The expression of mutant Ca2+-insensitive CaM (via ade-
novirus) in adult guinea-pig cardiomyocytes also prevents CDI
and causes dramatic AP prolongation (Alseikhan et al., 2002).
Moreover, some human patients with arrhythmias resembling
long QT syndrome have linked mutations in the Ca2+ bind-
ing domains in one of the three CaM genes (which otherwise
encode the identical CaM protein; Crotti et al., 2013). A loss of
CDI also characterizes the more common pathologic condition of
heart failure (HF), where marked AP prolongation and associated
defective Ca2+ cycling have been reported (Beuckelmann et al.,
1992). It is interesting to note that, at first, the down-regulation of
repolarizing K+ currents (Ito and IK1) was thought to be respon-
sible for the increased APD seen in HF. Only in the late 1990s
the pivotal role of CDI became clear, when it was first proposed
in a theoretical study in dog (Winslow et al., 1999), and then
experimentally observed in a guinea pig model of HF (Ahmmed
et al., 2000). So clearly defective ICa CDI can be arrhythmogenic
in people.
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FIGURE 1 | Inactivation of cardiac Ca2+ channel. (A) Normalized ICa, IBa,
and INS elicited by a square voltage pulse at room temperature to 0mV
(except INS at −30mV to obtain comparable activation state). ICa was
recorded under both perforated patch (where normal SR Ca2+ release and
Ca2+ transients occur) and ruptured patch conditions with cells dialyzed
with 10mM EGTA (to prevent global Ca2+ transients). IBa was also
recorded with ruptured patch (with 10mM EGTA in the pipette).
Extracellular [Ca2+] and [Ba2+] were both 2mM and INS was measured in
divalent-free conditions (10mM EDTA inside and out) with extracellular
[Na+] at 20mM and intracellular [Na+] at 10mM. Peak currents were 1370,
808, 780, and 5200 pA and were attained at 5, 7, 10, and 14ms for ICa
(perforated), ICa (ruptured), IBa and INS respectively, with t1/2 of current
decline of 17, 37, 161, and > 500ms respectively. (B) Amplitude of INS and
ICa through LTCC (at −10mV) after 500ms pulses to the indicated Em in
guinea-pig ventricular myocytes (modified from Bers, 2001 with permission,
data from Hadley and Hume, 1987).
ICa DURING THE AP CHANGES WITH INCREASING
FREQUENCY AND Ca2+ LOADING
APD regulation is fundamental to control the Ca2+ level in
myocytes, which is functionally important with respect to the
Ca2+ requirements for myofilament activation, and thus contrac-
tility. Indeed, CDI is a physiological negative feedbackmechanism
that limits excessive Ca2+ entry in myocytes. When the myocyte
has relatively high Ca2+ load, a large Ca2+ transient enhances
ICa inactivation (limiting further Ca2+ influx). Conversely, when
myocyte Ca2+ is low and SR Ca2+release is small, there is less
CDI and enhanced Ca2+ entry that increases intracellular Ca2+
content (Puglisi et al., 1999; Eisner et al., 2000; Bers and Grandi,
2009). Notably, Na+/Ca2+ exchange also participates in this neg-
ative feedback (i.e., higher Ca2+ transients limit Ca2+ entry
and increase Ca2+ extrusion from the myocyte via Na+/Ca2+
exchange).
The time course of ICa during the AP is significantly different
compared to that seen during a square voltage pulse [Figure 2A,
rabbit ventricular myocyte, 25◦C, with 10mM EGTA to prevent
Ca2+ transients (Yuan et al., 1996)]. Peak ICa during the AP is
lower and occurs later than during a square pulse, with larger
ICa late in the AP. The later ICa peak is because at the AP peak
(+50mV) Ca2+ channels activate rapidly, but the driving force
for Ca2+ (Em–ECa) is initially low, because Em is close to the
reversal potential for ICa (ECa ∼ +60mV). As Em repolarizes,
the driving force increases faster than channel inactivation, pro-
ducing a larger current at later times during the AP (Sah et al.,
2002). Sipido et al. (1995) first investigated how Ca2+ released
from the SR modulates ICa performing “classic” voltage-clamp
experiments, and observed that CDI increases as SR Ca2+ release
gets larger. Our group confirmed this observation in a more
“physiological” condition, as shown in Figure 2B, where repeated
AP-clamps are performed as the SR Ca2+ stores are reloaded, such
that contractions get progressively larger (beat 1–10; Puglisi et al.,
1999). One can see the contribution of SR Ca2+ release to CDI
as the Ca2+ transients and contractions get larger. Integration of
the Ca2+ influx via ICa during these ten pulses (which approach
the steady state) shows that the ICa-dependent influx decreases
from 12 to 6μmol/L cytosol, indicating that ICa inactivation due
to SR Ca2+ release decreases net Ca2+ influx by about 50%.
These experiments were done at both 25 and 35◦C. At 35◦C
peak ICa occurs earlier and is higher, but also inactivates faster
and the AP duration is also shorter. The net result is that there
is very little difference between these temperatures for the inte-
gral of Ca2+ influx during the AP (with SR Ca2+ release fully
functional).
Using a combination of AP and square voltage-clamp proto-
cols, Linz and Meyer (1998) assessed the time-course of ICa inac-
tivation during the AP in different Ca2+ homeostasis conditions.
Their analysis pointed out that, in physiological condition, CDI
is the overwhelmingly dominant inactivation on the time scale
of an AP, as recapitulated in the theoretical study by Greenstein
and Winslow (2002). Moreover, Linz and Meyer (1998) showed
that CDI is mostly controlled by Ca2+ released from the SR dur-
ing the initial part of the AP, then by Ca2+ entered through the
LTCCs. These results are well described by our recent compu-
tational study that updated the balance of VDI and CDI in the
context of a detailed Ca2+ cycling electrophysiological myocyte
model (Morotti et al., 2012).
At increased heart rates, there is typically an increase in Ca2+
transient amplitude (known sometimes as the positive force-
frequency relationship) in normal hearts in species other than rat
and mouse (Bers, 2001). The higher Ca2+ transients also typically
decline faster at high heart rates (known a frequency-dependent
acceleration of relaxation; Bers, 2001). Thus, ICa inactivation
is expected to be faster, based on the above discussion. The
higher heart rate could also shorten the diastolic interval and
increase diastolic [Ca2+]i, which might reduce ICa availability.
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FIGURE 2 | ICa inactivation during the AP. (A) Rabbit ventricular myocytes (at
25◦C) were voltage-clamped with either a square voltage step or an AP
waveform (measured from 5 other cells under physiological conditions). All
other currents were blocked, e.g., by replacement of K+ with Cs+ and Na+
with TEA (inside and out) and cells were dialyzed with 10mM EGTA to prevent
Ca2+ transients (data from Yuan et al., 1996, modified from Bers, 2001 with
permission). (B) After SR Ca2+ was depleted by a brief caffeine-application
(with Na+), a series of AP-clampswere given, and contraction and ICa recovered
to steady state over 10 sequential pulses at 25◦C in rabbit ventricular myocyte
(modified from Bers, 2001 with permission, data from Puglisi et al., 1999).
Indeed, while ICa recovery from inactivation is classically time and
Em-dependent (Hadley and Hume, 1987), we showed that eleva-
tions of [Ca2+]i could slow recovery from inactivation, especially
under conditions where SR Ca2+ uptake is depressed and diastolic
Em is slightly depolarized (Altamirano and Bers, 2007), as can be
the case in human HF (Sipido et al., 1998). This sort of diastolic
[Ca2+]i effect on LTCC availability is probably of only minor rel-
evance under normal physiological conditions and heart rates in
healthy hearts, but may be more of a factor under pathophysio-
logical conditions. That is, in HF there is an increased likelihood
that peak ICa will decrease at high heart rates, and that might con-
tribute to limiting the more negative force-frequency relationship
observed in HF (Sipido et al., 1998).
ICa FACILITATION IS CaMKII-DEPENDENT
Ca2+-DEPENDENT FACILITATION OF ICa: EARLY FUNCTIONAL
CHARACTERISTICS
Several early studies reported progressive increases in ICa ampli-
tude and prominent slowing of inactivation that was observed
during increased frequency of voltage-clamp pulses from physio-
logical holding potentials (∼ −80mV), as shown in the example
in Figure 3 (Lee, 1987; Boyett and Fedida, 1988; Tseng, 1988;
Hryshko and Bers, 1990). This phenomenon is not reproduced
if holding Em is more depolarized (e.g., −40mV) where a neg-
ative staircase is observed, or in the absence of Ca2+ (e.g., when
Ba2+ is the charge carrier). This ICa staircase was also stronger
when local Ca2+ influx was amplified by SR Ca2+ release. Thus,
this phenomenon is termed Ca2+-dependent facilitation of ICa.
CDF and CDI co-exist under physiological conditions, and
this may be why ICa facilitation was masked by holding Em
near −40mV. That is, recovery from inactivation at that Em is
slow, so the records were dominated by a negative ICa staircase
that was attributable to CDI and incomplete ICa recovery from
inactivation. It has been proposed that the facilitatory mecha-
nism may partly offset reduced Ca2+ channel availability at high
heart rates (caused by direct CDI), contributing to improving
cardiac performance during exercise (Ross et al., 1995). While
CDI responds rapidly (in response to local [Ca2+]i during the
same beat), CDF occurs more slowly (over several beats). Indeed,
biphasic effects of [Ca2+]i on unitary ICa have been reported
(Hirano and Hiraoka, 1994). Some studies even claimed that pro-
gressive decrease in SR Ca2+ release (negative staircase in rat)
and CDI are responsible for the observed CDF (Guo and Duff,
2003, 2006). However, because CDF is quite similar in species that
exhibit positive Ca2+ transients staircases and even when SR Ca2+
release is blocked this seems unlikely to be the case (Hryshko and
Bers, 1990).
CDF IS CaMKII-DEPENDENT: MECHANISTIC STUDIES
About 20 years ago three groups independently demonstrated
that Ca2+-dependent ICa facilitation is mediated by CaMKII-
dependent phosphorylation of LTCC (Anderson et al., 1994; Xiao
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FIGURE 3 | Ca2+-dependent facilitation of ICa. ICa at 0.5Hz (from −90
to 0mV) after a 2min rest period in a ferret ventricular myocyte. The
first post-rest pulse (PR) and the second, third and steady state (SS)
pulses are shown in (A) and the whole post-rest ICa “staircase” in
(B) (modified from Bers, 2001 with permission, data from Hryshko and
Bers, 1990).
et al., 1994; Yuan and Bers, 1994). Xiao et al. (1994) also observed
that sarcolemmal CaMKII activation correlates qualitatively with
the changes in ICa. All three studies reported that pharmacological
inhibition of CaMKII abolishes CDF in mammalian cardiomy-
ocytes (Figures 4A–D). Anderson’s group extended this work by
characterizing the CaMKII-dependent effect on single channel ICa
recorded in excised inside-out patches (Dzhura et al., 2000). They
showed that addition of activated CaMKII to the cytoplasmic side
of the sarcolemma results in phosphorylation of the LTCC com-
plex, inducing high-activity (mode 2) gating that is characterized
by long frequent openings (Figures 4E,F), consistently with the
macroscopic effect of CDF.
Since CDF is observed when cells are dialyzed with 10mM
EGTA (but is abrogated by 20mM BAPTA), the active CaMKII
must be highly localized near the channels (Hryshko and Bers,
1990). Although the CaMKII-dependent phosphorylation of
LTCC has been studied for a long time, the molecular bases of
this phenomenon are not still completely understood. In partic-
ular, it is debated which LTCC subunit is involved, since multiple
candidate phosphorylation sites have been identified in both the
pore-forming α1C subunit and the auxiliary β2 subunit (Sun and
Pitt, 2011).
Some early studies suggested that the IQmotif on the α1C sub-
unit is involved in CDF (Wu et al., 2001). Wu et al. showed that in
rabbit ventricular myocytes ICa facilitation could be nearly abol-
ished by the CaMKII inhibitory peptide AC3-I, but could then
be rescued by cell dialysis with a peptide resembling the Ca2+
channel IQ domain, called “IQ-mimetic peptide.” This may also
relate to early studies of CDI with wild-type and mutant α1C in
Xenopus oocytes, where it was found that isoleucine point muta-
tions in the IQ domain could either enhance (Ile to Ala) or abolish
(Ile to Glu) CDF (Zuhlke et al., 1999).
More recent studies in heterologous cells indicate that CaMKII
may directly bind and phosphorylate the α1C subunit. In oocytes
CaMKII could phosphorylate the α1C subunit (Hudmon et al.,
2005). Hudmon et al. (2005) also showed that tethering of
CaMKII to the Cav1.2 C-terminus is an essential molecular
feature of CDF, because mutations to a putative C-terminus
binding site prevent CDF. Other recent studies support the idea
of CaMKII-dependent phosphorylation of the pore-forming α1C
subunit, and propose possible phosphorylation sites. Erxleben
et al. (2006) studied the increase in mode 2 activity of rabbit
Cav1.2 channels seen in neurons in two pathologic conditions
of cyclosporin neurotoxicity and Timothy syndrome. They found
that mode 2 activity increases through a CaMKII-dependent
mechanism involving respectively Ser-1517 (at the end of the S6
helix in domain IV), and Ser-439 (at the end of the S6 helix
in domain I). Wang et al. (2009) expressed guinea pig Cav1.2
channel in Chinese hamster ovary, and found that CaMKII phos-
phorylates Thr-1603 residue (Thr-1604 in rabbit) within the
pre-IQ region in the C-terminal tail of the Cav1.2 channel. In
HEK cells ICa facilitation was decreased by the single mutations
(to Ala) in Ser-1512 and Ser-1570 (two serines that flank the
C-terminal EF-hand motif), and abolished by the double muta-
tion S1512A/S1570A (Lee et al., 2006). Furthermore, Blaich et al.
(2010) observed impaired ICa facilitation in mice with knockin
mutations at the Ser-1512 and Ser-1570 (to Ala) phosphoryla-
tion sites, and confirmed that Cav1.2 channel is modulated by
CaMKII-dependent phosphorylation in the murine heart.
In contrast to that data implicating sites on the pore-forming
α1 subunit, other results point to CaMKII-dependent phospho-
rylation of regulatory β subunits. In particular, it was reported
that CDF is mediated by phosphorylation of the β2a subunit,
at Thr-498 in isolated adult rat (Grueter et al., 2006) and rab-
bit (Koval et al., 2010) ventricular myocytes. Grueter et al. (2006)
first investigated whether, and in which conditions, CaMKII can
directly bind to a β2a subunit (expressed as a glutathione S-
transferase, GST, fusion protein). They found such high affinity
binding when CaMKII was in the active (i.e., autophosphory-
lated) state. By screening a library of GST-fusion proteins, they
identified the β2a region that bound to CaMKII, and verified
that CaMKII would phosphorylate this region. Among the dif-
ferent possible phosphorylation sites present in this region, only
the mutation of Thr-498 to Ala (T498A) impaired CaMKII-
phosphorylation. Expressing T498A β2a with Cav1.2 in tsA201
cells resulted in impaired CaMKII-dependent increase in channel
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FIGURE 4 | CaMKII-dependent regulation of ICa. Superimposed ICa traces
from the first (I1) and tenth (I10) voltage-clamp pulse from −90 to 0mV at
2Hz in a single rabbit ventricular myocyte obtained in control condition (A) or
after 10min equilibration with the CaMKII inhibitor KN-62 (1μM) (B); I1 and
I10 obtained in the two conditions are respectively shown (superimposed) in
panels (C,D) (modified from Yuan and Bers, 1994 with permission). (E) A
single LTCC current (channel openings are seen as downward deflections
from baseline) is elicited by repetitive depolarizing voltage-clamp steps (from
−70 to 0mV) and reveals infrequent, brief openings under basal conditions
(upper panel). CaMKII (bottom) causes frequent and prolonged LTCC
openings compared with baseline. Panel (F) shows that the probability of
LTCC opening during a depolarizing voltage-clamp step is dramatically
increased upon addition of CaMKII, compared with basal conditions (modified
from Anderson, 2004 with permission, data from Dzhura et al., 2002).
open probability, and ablation of CaMKII-mediated whole cell
ICa facilitation has been observed in rat cardiomyocytes (Grueter
et al., 2006). It was also shown that Leu-493 present in the β2a
and β1a (but not present in β3 and β4) subunits was impor-
tant for high affinity CaMKII binding, and that mutation of
Leu-493 to Ala (L493A) substantially reduced CaMKII bind-
ing, but did not interfere with β2a phosphorylation at Thr-498
(Grueter et al., 2008; Abiria and Colbran, 2010). Other studies
have shown that overexpression of β2a, which can dramati-
cally increase ICa, causes cellular Ca2+ overload, and facilitates
arrhythmogenesis, apoptosis and hypertrophic signaling (Chen
et al., 2005; Koval et al., 2010; Chen et al., 2011). Koval et al.
(2010) showed that prevention of intracellular Ca2+ release by
ryanodine, by inhibition of CaMKII activity, or expression of β2a
T498A or L493A mutants could reduce Ca2+ entry and improved
cell survival.
Despite much effort aimed at the detailed molecular mecha-
nism for CaMKII-dependent ICa facilitation, more work will be
required to develop a fully satisfying explanation. It may be that
sites on both the α and β subunit are important, that the α-β
subunit interaction is critical, and there may also be more than
one CaMKII binding domain and phosphorylation target. The
CaM involved in activating the CaMKII that is associated with the
LTCC seems unlikely to be the same CaM that is involved in CDI,
since that CaM appears dedicated and bound strongly even at low
[Ca2+]i not to fully dissociate from the CDI regulatory sites.
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ARRHYTHMOGENIC CONSEQUENCES OF
CaMKII-DEPENDENT ICa EFFECTS
CaMKII-dependent modulation of ICa is characterized by both
increased current amplitude and slowed inactivation, and can
result in an overall increase in Ca2+ entry, which can be
pro-arrhythmic. Intracellular Ca2+ overload is associated with
increased propensity of spontaneous SR Ca2+ release, which can
lead to delayed afterdepolarizations (DADs) because of the tran-
sient inward current carried by the Na+/Ca2+ exchanger (in the
Ca2+ extrusion mode). In a theoretical study (Morotti et al.,
2012), we also showed that, when CDI is dramatically impaired,
the same mechanism can be responsible for the development
of early afterdepolarizations (EADs) during the prolonged AP
plateau. It has also been shown that the CaMKII-dependent
shift of LTCC into mode 2 gating can explain the global ICa
facilitation typically measured (Hashambhoy et al., 2009). That
group also showed that higher mode 2 activity can favor the
development of EADs because of ICa reactivation during the AP
plateau (Tanskanen et al., 2005; Hashambhoy et al., 2010). For a
further detailed review aboutmathematical modeling of CaMKII-
mediated regulation of LTCC see the accompanying article in this
series by Greenstein et al. (2014).
Studying different conditions in which the AP is forcibly
prolonged, Anderson’s group obtained the first experimental
evidence for the role of CaMKII in the development of afterde-
polarizations in rabbit ventricular myocytes. They showed that
the development of EADs (due to ICa reactivation during the pro-
longed plateau) is prevented by CaMKII inhibition (with KN-93
or AC3-I) (Anderson et al., 1998; Wu et al., 1999a), and that AC3-
I also prevents the development of DADs caused by the increased
Na+/Ca2+ exchanger current (Wu et al., 1999b). They observed
the development of EADs due to CaMKII-dependent enhance-
ment of LTCC open probability in a transgenic mouse model
of cardiac hypertrophy as well (Wu et al., 2002). This model,
together with increased CaMKII, showed an increased propensity
for ventricular arrhythmias, which can be prevented by CaMKII-
inhibition. Increased CaMKII levels have been observed also in
a murine model of pressure overload HF (Wang et al., 2008). In
this model, CaMKII-dependent activation of ICa is already maxi-
mal and CDF cannot be induced, suggesting an important role of
CaMKII in remodeling in failing myocytes.
It is now well known that CaMKII is hyperactive in several
forms of cardiac diseases (Anderson et al., 2011; Swaminathan
et al., 2012; Vincent et al., 2014), and interesting insights about
ICa modulation have been provided by studies on animal mod-
els in which CaMKII is overexpressed or inhibited. Both chronic
CaMKII overexpression in transgenic mouse myocytes and acute
overexpression in rabbit myocytes cause increase in ICa amplitude
and slowing in inactivation (consistent with CDF), and ICa could
be reduced back to control levels by blocking CaMKII with KN-93
or AIP (Maier et al., 2003; Kohlhaas et al., 2006). Conversely, two
different mouse models with CaMKII inhibition (Zhang et al.,
2005; Picht et al., 2007) are characterized by complete inhibition
of ICa facilitation. Notably, Picht et al. used a CaMKII inhibitory
peptide (AIP) genetically targeted to the SR, consistent with the
notion that CaMKII involved in ICa facilitation being localized at
junctions between the SR and sarcolemma. Interestingly, Xu et al.
(2010) showed that ICa facilitation was significantly reduced in a
CaMKII-knockout mouse model. They also found an increase in
Cav1.2 expression, which may be due to a compensatory mech-
anism for the reduced CaMKII-dependent facilitation over the
long-term CaMKII inhibition.
In fact, other studies suggest that CaMKII activity can influ-
ence LTCC expression (Meffert et al., 2003; Shi et al., 2005;
Ishiguro et al., 2006), based on the evidence that CaMKII phos-
phorylates the nuclear factor-kappaB (NFkB) component p65,
causing its nuclear translocation, and consequent release of
NFkB-dependent inhibition of Cav1.2 channel expression. Xu
et al. (2010) found a significant reduction of p65 nuclear translo-
cation in their transgenic myocytes.
Beyond LTCC, CaMKII influences many other targets within
the cell (Bers and Grandi, 2009), many of which play impor-
tant roles in modulating the cardiac ECC. An accurate analy-
sis of the arrhythmogenic consequences of CaMKII-dependent
LTCC phosphorylation cannot neglect, among the various targets,
the effects on phospholamban (PLB) and ryanodine receptors
(RyRs). CaMKII phosphorylation of PLB releases its inhibition
on Ca2+-sensitivity of SR Ca2+ pump (Simmerman and Jones,
1998), thus causing an increase in the pump affinity for Ca2+.
When RyRs are phosphorylated, their sensitivity for cytosolic
Ca2+ (Li et al., 1997; Wehrens et al., 2004) and passive leak
(Ai et al., 2005; Guo et al., 2006) are enhanced. Thus, con-
sequences of CaMKII-dependent phosphorylation of RyRs and
PLB are increased SR Ca2+ uptake and release, resulting in
an increase in Ca2+ transient amplitude, which further acti-
vates CaMKII, and this can have arrhythmogenic consequences.
Integrated mathematical models have been helpful in quanti-
tatively understanding the complex interactions among these
players. Soltis and Saucerman (2010) demonstrated the key role
of RyR phosphorylation in the prominent positive feedback that
associates the CaMKII-dependent increase in Ca2+ signal to a
further increase in CaMKII activity. They also showed that the
CaMKII-Ca2+-CaMKII feedback is enhanced by β-adrenergic
stimulation (which further enhances Ca2+ signal). We recently
extended their work, by studying the synergy of Na+ handling
with Ca2+ and CaMKII signaling, since CaMKII hyperactivity
in HF has also been associated with late INa and intracellu-
lar [Na+] ([Na+]i) overload (Wagner et al., 2006; Grandi and
Herren, 2014). We found that a significant gain in [Na+]i (∼ 3–
4mM), which is what happens in HF (Despa et al., 2002), induces
an increase in Ca2+ and consequent Ca2+-dependent CaMKII
activation, which in turn enhances Na+ and Ca2+ signals, leading
to a pro-arrhythmic condition. We also showed that, in condi-
tion of CaMKII overexpression, the CaMKII-Na+-Ca2+-CaMKII
feedback is predominant, and leads to a hyper-phosphorylation
of RyRs responsible for spontaneous SR Ca2+ release and DADs
development (Morotti et al., 2014).
CONCLUDING REMARKS
CaMKII has numerous targets in cardiac myocytes, and we
must assume that under normal physiological conditions this
orchestrates a response that is acutely adaptive. However,
when CaMKII becomes chronically activated in disease, by
autophosphorylation and oxidation (Anderson et al., 2011;
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Swaminathan et al., 2012), O-GlcNAcylation (Erickson et al.,
2013) or possibly nitrosylation (Gutierrez et al., 2013), these
regulatory systems may become maladaptive. The key CaMKII-
dependent regulation of LTCC is ICa facilitation, a moderate
increase in ICa amplitude and slowing of ICa inactivation in
response to changes in heart rate. It seems likely that ICa facili-
tation is a normal adaptation to increased heart rate, to ensure
Ca2+ channel availability and the integrity of ECC (which might
otherwise be depressed by CDI or encroachment into recovery
from inactivation). However, when this system is chronically on
in pathological states it may contribute to inappropriate Ca2+
loading of the myocytes, and contribute to worsening pathology
via poor diastolic function or arrhythmias triggered by EADs or
DADs, altered ICa restitution or cardiac alternans. The detailed
molecular mechanisms remain to be fully resolved, but work over
the past 10–20 years has paved the way for further clarification in
the near future.
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